Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in Kawasaki disease.

A F Freeman1, S T Shulman

  • 1Department of Pediatrics, The Children's Memorial Hospital, Northwestern University Medical School, Chicago, Illinois 60614-3363, USA. freeman_alexandra@hotmail.com

Current Opinion in Infectious Diseases
|April 20, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITA.

The Journal of allergy and clinical immunology·2026
Same author

IL-10 signaling in dendritic cells controls IL-1β-mediated IFNγ secretion by human CD4<sup>+</sup> T cells: relevance to inflammatory bowel disease.

Mucosal immunology·2019
Same author

Arterial immune protein expression demonstrates the complexity of immune responses in Kawasaki disease arteritis.

Clinical and experimental immunology·2017
Same author

Correction: ERBIN deficiency links STAT3 and TGF-β pathway defects with atopy in humans.

The Journal of experimental medicine·2017
Same author

ERBIN deficiency links STAT3 and TGF-β pathway defects with atopy in humans.

The Journal of experimental medicine·2017
Same author

Therapeutic drug monitoring of posaconazole oral suspension in paediatric patients younger than 13 years of age: a retrospective analysis and literature review.

Journal of clinical pharmacy and therapeutics·2016

Kawasaki disease is a leading cause of acquired heart disease in children. Research is exploring its infectious causes, inflammatory responses, and treatments for resistant cases.

Area of Science:

  • Pediatrics
  • Cardiology
  • Immunology

Background:

  • Kawasaki disease is the primary cause of acquired heart disease in children in North America and Japan.
  • Understanding the etiology and pathogenesis of Kawasaki disease is crucial for effective management.

Purpose of the Study:

  • To review recent developments and controversies surrounding Kawasaki disease.
  • To highlight advances in understanding its infectious causes, inflammatory mechanisms, and therapeutic strategies.

Main Methods:

  • Literature review of recent studies on Kawasaki disease.
  • Analysis of immunohistochemistry findings related to coronary artery lesions.
  • Examination of research on treatment resistance and long-term outcomes.

Related Experiment Videos

Main Results:

  • Growing evidence supports an infectious origin, with ongoing debate on antigen involvement (conventional vs. superantigen).
  • Vascular growth factors are implicated in coronary artery lesion formation.
  • Focus on identifying and treating therapy-resistant patients and understanding long-term prognosis.

Conclusions:

  • Recent advances provide insights into the etiology, pathogenesis, and therapy of Kawasaki disease.
  • Further research is needed to fully elucidate the complex mechanisms driving this condition.
  • Improved understanding will aid in developing more targeted and effective treatments for affected children.